Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
TNF Pharmaceuticals ( (TNFA) ) has shared an announcement.
On September 2, 2025, TNF Pharmaceuticals announced a licensing agreement with LightSolver for a laser-based processing accelerator aimed at revolutionizing cryptocurrency applications. This strategic move positions TNF as a pioneer in light-based computing for blockchain, potentially reducing energy costs by up to 90%. Concurrently, TNF secured a $7 million private placement to fund its new venture, reflecting its shift towards innovative computing solutions and enhancing its market positioning.
More about TNF Pharmaceuticals
TNF Pharmaceuticals operates in the pharmaceutical industry, focusing on therapeutic platforms including TNF-alpha inhibitors and Supera-CBD. The company is now expanding into the cryptocurrency sector through a strategic partnership with LightSolver, acquiring exclusive rights to innovative laser-based computing technology for blockchain applications.
Average Trading Volume: 52,967,102
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.53M
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.